In collaboration with Global Antibiotic Research & Development Partnership (GARDP)
Presentation Details | Videos |
---|---|
Opening remarksProfessor Laura Piddock, Head of Scientific Affairs, Global Antibiotic R&D Partnership (GARDP) |
Watch Presentation Download Presentation |
The risks of clinical development from the perspective of the antibacterial discovery scientistDr David Shlaes, Former Professor of Medicine, Case Western Reserve University, Ohio, USA |
Watch Presentation Download Presentation |
Overview of new antibiotics in developmentProfessor David Livermore, Professor of Medical Microbiology, University of East Anglia |
Watch Presentation Download Presentation |
Overview of new antifungals in developmentProfessor David Denning, Professor of Infectious Diseases in Global Health, University of Manchester |
Watch Presentation Download Presentation |
Things clinicians don’t often consider (CMC, GLP toxicology, Phase I studies)Dr Lauren Walker, Clinical Lecturer at Royal Liverpool University Hospital |
Watch Presentation Download Presentation |
PK-PD programs for drug developmentProfessor George Drusano, University of Florida and an Institute Director (Institute for Therapeutic Innovation) |
Watch Presentation Download Presentation |
Invited paper – Identifying carbapenem and amikacin-sparing first-line combination therapy for neonatal sepsis in high extended-spectrum beta-lactamase (ESBL) prevalence settingsDr Joe Standing, Principal Research Associate (MRC fellow), UCL Great Ormond Street Institute of Child Health |
Watch Presentation Download Presentation |
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinationsDr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology, University of Liverpool |
Watch Presentation Download Presentation |
Metallobetalactamases and development of new compoundsDr Martin Everett, Chief Scientific Officer, Antabio |
Watch Presentation Download Presentation |
Invited paper – REVIVE – a programme to support and connect the antimicrobial R&D communityAstrid Pentz-Murr, Community manager REVIVE, GARDP |
Watch Presentation Download Presentation |
Stimulating Antibiotic R&D through links to sustainable use and novel economic incentivesDr Ursula Theuretzbacher, Founder, Center for Anti-Infective Agents |
Watch Presentation Download Presentation |
Developing a new drug for STIsDr Emilie Alirol, Project Leader, Sexually Transmitted Infections, Global Antibiotic R&D Partnership (GARDP) |
Watch Presentation Download Presentation |
Clinical Trial Design for new antimicrobials: adultsMr Aaron Dane, Director, DaneStat Consulting Limited |
Watch Presentation Download Presentation |